25th BioPharma Drug Discovery Nexus 2026

April 29th & 30th 2026

Radisson Blu Hotel, Zurich Airport, Switzerland

0
Days
0
Hours
0
Mins
0
Secs
Be A Participant

Accelerating Innovation in BioPharma Drug Discovery



The BioPharma Drug Discovery Nexus is an exclusive, invitation-only forum that brings together senior discovery scientists, R&D leaders, and industry pioneers with innovative technology partners and solution providers shaping the future of drug discovery.

The conference agenda is thoughtfully curated to address critical challenges across target identification, lead optimization, translational research, and emerging discovery platforms. Attendees will gain insight into cutting-edge scientific advancements, evolving market dynamics, and proven strategies adopted by trailblazing organizations to accelerate discovery pipelines and deliver next-generation therapeutics.

A Premium, All-Inclusive Experience

Every delegate is treated as a VIP. From curated networking sessions to carefully designed experiences, the Nexus fosters both professional engagement and personal comfort, creating the ideal environment for productive dialogue and long-lasting connections.

Driving Conversations in Drug Discovery

This is not a conventional tradeshow. The Nexus is purposefully structured to bring together senior leaders in a focused setting that supports strategic discussions, peer learning, and professional exchange.

Curated One-to-One Engagements

Engage with fellow delegates through dedicated one-to-one meetings throughout the event. This flexible format allows you to explore strategic collaborations, exchange insights, and maximize every interaction.

Who Should Attend?

By Seniority Level

Top Management
(C-Suite, Presidents)
Senior Management
(VPs, Heads)
Middle Management
(Directors, Managers)
Others
30%
43%
22%
5%
  • Biology
  • Neuroscience and Preclinical Research
  • Protein Engineering
  • Target Biochemistry
  • Computational Designing
  • In Vivo Pharmacology
  • Research & Product Development
  • Drug Discovery
  • Pharmacology and Pharmacokinetics
  • Medicinal Chemistry
  • Translational Research
  • High-Throughput Protein Expression
  • Biomarker Research
  • R&D
  • Manufacturing in Cell Therapy
  • Drug Design
  • Bioinformatics and AI/ML
  • Therapeutic Antibodies
  • Structural Chemistry
  • Molecular Design
  • Preclinical Development
  • Global Upstream and Cell Line Development
  • Nonclinical Development
  • Oncology Cell Therapy Innovation
  • DMPK
  • Nucleic Acid Drug Discovery
  • Cancer Biology
  • Toxicology
  • Vaccine Immunology
  • Modeling & Simulation
  • mRNA Protein Therapeutics
  • Small Molecule Research
  • Data Science, CADD
  • Synthetic Biology
  • Machine Learning
  • Molecular Modelling

Our Industry Leaders

Meet the Innovators Driving the Next Era of Drug Discovery

Dr. Ahmet Can Berkyurek
Dr. Ahmet Can Berkyurek

CEO & Founder

CamMed Therapeutics Ltd

LinkedIn
Dr. Natalia Dovlatova
Dr. Natalia Dovlatova

CEO & Founder

Platelet Services

LinkedIn
Amine Namouchi
Amine Namouchi

Principal Scientist

Nykode Therapeutics

LinkedIn
Benyahia Chebel
Benyahia Chebel

Sales and Business Development

Biognosys AG

LinkedIn
Shaina Huang,PhD
Shaina Huang,PhD

R&D Scientist

GSK

LinkedIn
Daniel Couto
Daniel Couto

Senior Scientist, Leader Molecular Interactions Team

CSL

LinkedIn
Sophia Qiqun Zeng
Sophia Qiqun Zeng

Associate Director, Biology

Opna Bio

LinkedIn
Parashar Dhapola, PhD
Parashar Dhapola, PhD

CEO

Nygen

LinkedIn
Luca Pellegrinet
Luca Pellegrinet

Director, Preclinical Development

T-Therapeutics Ltd

LinkedIn
Sonia Novo
Sonia Novo

Principal Scientist-in vitro ADME

UCB

LinkedIn
Zeno Albisser
Zeno Albisser

Chief Executive Officer

Hemispherian

LinkedIn
Hazel Mak
Hazel Mak

Senior Research Scientist

AstraZeneca

LinkedIn
Yas Heidari
Yas Heidari

Global Product Manager

Biotage

LinkedIn
Lawrence Tam
Lawrence Tam

Vice President of Research & Development

Sania Therapeutics

LinkedIn
Adam Robertson
Adam Robertson

Chief Scientific Officer

Hemispherian

LinkedIn
Manel Kraiem
Manel Kraiem

Chief Development Officer

Skymab Biotherapeutics

LinkedIn
Gergely Toth
Gergely Toth

Chief Executive Officer, Chief Scientific Officer and Founder

Cantabio Pharmaceuticals, Inc.

LinkedIn
Annelise Soulier
Annelise Soulier

Co-founder, CSO

Neobe Therapeutics

LinkedIn
Johan Luthman
Johan Luthman

EVP & Head R&D

Lundbeck

LinkedIn
Dr. Martin Schwill
Dr. Martin Schwill

Head of Artificial Intelligence, Bioinformatics, Computer Aided Drug Discovery

Adularia

LinkedIn
Paula Cerqueira
Paula Cerqueira

Vice President of Scientific Strategy

Sania Therapeutics

LinkedIn
Devrim Pesen Okvur
Devrim Pesen Okvur

Chief Technology Officer

Initio Cell

LinkedIn
Andreas Hollenstein
Andreas Hollenstein

Principal Scientist, Immunosafety

Roche

LinkedIn
David Moreno Delgado
David Moreno Delgado

Associate Director Assay Development and Technologies

Galapagos

LinkedIn
Emzo de los Santos
Emzo de los Santos

Principal Scientist (ML NBE)

UCB

LinkedIn
Mate Ongenaert
Mate Ongenaert

Principal scientist II- Computational Biology

Johnson & Johnson Innovative Medicine

LinkedIn
Kelly Zalocusky
Kelly Zalocusky

Senior Director of Computational Biology, Neuroscience

Recursion

LinkedIn
Dr. Fengbo Ren
Dr. Fengbo Ren

Founder & CEO

Fovus Corporation

LinkedIn
Bart Wuurman
Bart Wuurman

CEO

Apaxen

LinkedIn
Hugo Ceulemans
Hugo Ceulemans

Senior Director- Drug Discovery Data Sciences

Johnson & Johnson Innovative Medicine

LinkedIn
Bastiaan Bergman
Bastiaan Bergman

VP of AI

BenevolentAI

LinkedIn
Xavier Leroy
Xavier Leroy, PhD EMBA

Chief Executive Officer

RNA Mab Therapeutics

LinkedIn
Abbie Macmillan-Jones
Abbie Macmillan-Jones

Associate Principal Scientist

AstraZeneca

LinkedIn
Claudio Murgia
Claudio Murgia, DVM, PhD

Unit Head, Target & Disease Biology, Discovery Oncology

Roche

LinkedIn
David Pejoski
David Pejoski

Co-CEO

Adoram Therapeutics

LinkedIn
Dr Radha Krishnan
Dr Radha Krishnan

Executive Director, Head of Clinical Pathology, MSD UK

Merck

LinkedIn
Aurélien Rizk
Aurélien Rizk

Co-Founder & CSO

InterAx Biotech

LinkedIn
Christian Stocker
Christian Stocker

Scientist Protein Engineering

Anaveon Ag

LinkedIn

6 Reasons to Attend

Cutting-Edge Drug Discovery Science

Explore the latest advances in target identification, hit-to-lead optimization, and preclinical development.

Translational & Drug Discovery Relevance

See how discoveries move from lab to therapeutic development through real-world biopharma case studies.

AI, Omics & Novel Technologies

Discover how AI/ML, genomics, proteomics, and high-throughput screening are transforming drug discovery.

Expert Insights from Discovery Leaders

Engage with top scientists, medicinal chemists, and R&D leaders driving innovation in biopharma.

Collaborative Networking for Innovation

Connect with CROs, biotech innovators, and pharma partners to accelerate discovery pipelines.

Proven Platform for Breakthrough Ideas

With 25 successful editions, the event is a trusted hub for sharing impactful drug discovery research.

What to expect at
the 2026 Edition

  • Novel targets & modalities
  • Antibody & protein therapeutics
  • Data, AI & Computational Discovery
  • Translational biology, biomarkers & DMPK
  • Enabling Platforms & Tools

Connect with senior decision-makers, leading scientists, and innovative thinkers driving breakthroughs in drug discovery. Build meaningful collaborations that can accelerate your next therapeutic innovation.

25th Biopharma Drug Discovery Nexus, Zurich is your chance to explore the latest innovations, advance your expertise, and expand your professional network.

  • Cutting-edge plenaries with global drug discovery leaders
  • Hands-on workshops and real-world case studies
  • Focused networking to foster collaborations and partnerships

Our Partners

Our Previous Partners

Our Media Partners

Showcase Your Solutions at the 25th Drug Discovery Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative drug discovery solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of drug discovery and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real operational impact.

Schedule At a Glance

8:00 am - 8:15 am
Registration
8:15 am - 8:20 am
Welcome & Chairperson Address
8:25 am - 8:45 am
Presentation 1
8:50 am - 9:10 am
Presentation 2
9:15 am - 10:10 am
Panel Discussion 1
10:15 am - 11:45 am
Networking Break
11:45 am - 12:05 pm
Presentation 3
12:10 pm - 12:30 pm
Presentation 4
12:35 pm - 12:55 pm
Presentation 5
1:00 pm - 1:40 pm
Lunch Break
Hot Buffet Lunch will be Served.
1:40 pm - 2:00 pm
Presentation 6
2:05 pm - 3:00 pm
Panel Discussion 2
3:05 pm - 3:25 pm
Presentation 7
3:30 pm - 3:55 pm
Presentation 8
4:00 pm - 5:30 pm
Networking Break
5:35 pm - 5:40 pm
Closing Remarks
8:00 am - 8:15 am
Registration
8:15 am - 8:20 am
Welcome & Chairperson Address
8:25 am - 8:45 am
Presentation 1
8:50 am - 9:10 am
Presentation 2
9:15 am - 10:10 am
Panel Discussion 1
10:15 am - 11:45 am
Networking Break
11:45 am - 12:05 pm
Presentation 3
12:10 pm - 12:30 pm
Presentation 4
12:35 pm - 12:55 pm
Presentation 5
1:00 pm - 1:40 pm
Lunch Break
Hot Buffet Lunch will be Served.
1:40 pm - 2:00 pm
Presentation 6
2:05 pm - 3:00 pm
Panel Discussion 2
3:05 pm - 3:25 pm
Presentation 7
3:30 pm - 3:55 pm
Presentation 8
4:00 pm - 5:30 pm
Networking Break
5:35 pm - 5:40 pm
Closing Remarks

0

+

Seats

0

Hours

0

+

Speakers

0

+

Exhibitors

Testimonials

Venue

Radisson Blu Hotel

Name: Radisson Blu Hotel

Address: Zurich Airport, Rondellstrasse, 8058 Zurich, Switzerland

Parking: Available on-site

Hotel Reservation Link: We will be sharing a reservation link to help you secure accommodation at a special discounted rate.

CONFERENCE REGISTRATION

Secure your spot today.